JPH1175863A - ２５−ヒドロキシビタミンＤ３−１α−水酸化酵素および該酵素をコードするＤＮＡ - Google Patents

２５−ヒドロキシビタミンＤ３−１α−水酸化酵素および該酵素をコードするＤＮＡ

Info

Publication number
JPH1175863A
JPH1175863A JP9322651A JP32265197A JPH1175863A JP H1175863 A JPH1175863 A JP H1175863A JP 9322651 A JP9322651 A JP 9322651A JP 32265197 A JP32265197 A JP 32265197A JP H1175863 A JPH1175863 A JP H1175863A
Authority
JP
Japan
Prior art keywords
leu
arg
ala
val
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9322651A
Other languages
English (en)
Japanese (ja)
Other versions
JPH1175863A5 (cg-RX-API-DMAC7.html
Inventor
Hideji Anazawa
秀治 穴澤
Hiroko Shimada
弘子 嶋田
Seiji Sugimoto
整治 杉本
Tatsuo Suda
立雄 須田
Toshimasa Araki
敏正 新木
Yukio Saruta
享男 猿田
Tatsumi Ishimura
▲巽▼ 石村
Matsuhiko Hayashi
松彦 林
Osamu Wakino
修 脇野
Toshiaki Kadokawa
俊明 門川
Osamu Yoshida
理 吉田
Hiromichi Suzuki
洋通 鈴木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Priority to JP9322651A priority Critical patent/JPH1175863A/ja
Priority to US09/111,730 priority patent/US6274359B1/en
Priority to CA002237138A priority patent/CA2237138A1/en
Priority to EP98112865A priority patent/EP0890643A3/en
Priority to EP00124552A priority patent/EP1074627A3/en
Publication of JPH1175863A publication Critical patent/JPH1175863A/ja
Priority to US09/878,262 priority patent/US20020031798A1/en
Publication of JPH1175863A5 publication Critical patent/JPH1175863A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP9322651A 1997-07-10 1997-11-25 ２５−ヒドロキシビタミンＤ３−１α−水酸化酵素および該酵素をコードするＤＮＡ Pending JPH1175863A (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP9322651A JPH1175863A (ja) 1997-07-10 1997-11-25 ２５−ヒドロキシビタミンＤ３−１α−水酸化酵素および該酵素をコードするＤＮＡ
US09/111,730 US6274359B1 (en) 1997-07-10 1998-07-08 25-hydroxyvitamin D3-1α-hydroxylase and DNA encoding the hydroxylase
CA002237138A CA2237138A1 (en) 1997-07-10 1998-07-09 25-hydroxyvitamin d3-1.alpha.-hydroxylase and dna encoding the hydroxylase
EP98112865A EP0890643A3 (en) 1997-07-10 1998-07-10 25-Hydroxyvitamin D3-1a-hydroxylase and dna encoding the hydroxylase
EP00124552A EP1074627A3 (en) 1997-07-10 1998-07-10 25-hydroxyvitamin D3-1a-hydroxylase and DNA encoding the hydroxylase
US09/878,262 US20020031798A1 (en) 1997-07-10 2001-06-12 Antibody recognizing human 25-hydroxyvitamin D3-1a-hydroxylase

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP18539997 1997-07-10
JP9-185399 1997-07-10
JP9322651A JPH1175863A (ja) 1997-07-10 1997-11-25 ２５−ヒドロキシビタミンＤ３−１α−水酸化酵素および該酵素をコードするＤＮＡ

Publications (2)

Publication Number Publication Date
JPH1175863A true JPH1175863A (ja) 1999-03-23
JPH1175863A5 JPH1175863A5 (cg-RX-API-DMAC7.html) 2005-04-07

Family

ID=26503073

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9322651A Pending JPH1175863A (ja) 1997-07-10 1997-11-25 ２５−ヒドロキシビタミンＤ３−１α−水酸化酵素および該酵素をコードするＤＮＡ

Country Status (4)

Country Link
US (2) US6274359B1 (cg-RX-API-DMAC7.html)
EP (2) EP0890643A3 (cg-RX-API-DMAC7.html)
JP (1) JPH1175863A (cg-RX-API-DMAC7.html)
CA (1) CA2237138A1 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1024193A4 (en) * 1997-07-22 2004-12-15 Chugai Pharmaceutical Co Ltd METHOD FOR SCREENING GENES USING CELL CORE RECEPTORS.
US6096876A (en) * 1997-08-06 2000-08-01 Shriners Hospitals For Children 1-α-hydroxylase materials and methods
DE60021720T2 (de) 1999-05-04 2006-06-01 Strakan International Ltd. Androgen glykoside und die androgenische aktivität davon
US20030062225A1 (en) * 2001-10-03 2003-04-03 Stucky Paul A. Elevator load bearing assembly having a detectable element that is indicative of local strain
US7416899B2 (en) * 2002-07-29 2008-08-26 Tohoku Techno Arch Co., Ltd. Method and apparatus for measuring trace ingredients in water
ES2904546T3 (es) 2006-02-03 2022-04-05 Opko Renal Llc Tratamiento de la insuficiencia y deficiencia de vitamina D con 25-hidroxivitamina D2 y 25-hidroxivitamina D3
SI2037936T1 (sl) 2006-06-21 2014-11-28 Opko Renal, Llc Postopek zdravljenja in prepreäśevanja sekundarnega hiperparatiroidizma
CA2683628C (en) 2007-04-25 2018-03-06 Cytochroma Inc. Method of treating vitamin d insufficiency and deficiency
PT2148661E (pt) 2007-04-25 2013-03-06 Proventiv Therapeutics Llc Composições orais de libertação controlada compreendendo um composto de vitamina d e veículo ceroso
FI3225243T3 (fi) 2007-04-25 2025-10-13 Opko Renal Llc Menetelmä sekundaarisen hyperparatyreoosin turvalliseen ja tehokkaaseen hoitoon ja ehkäisyyn kroonisen munuaistaudin yhteydessä
US8962239B2 (en) 2008-04-02 2015-02-24 Opko Renal, Llc Methods useful for vitamin D deficiency and related disorders
CN105796530A (zh) 2010-03-29 2016-07-27 赛特克罗公司 用于降低甲状旁腺水平的方法和组合物
US8647616B2 (en) 2012-02-14 2014-02-11 Loma Linda University Agents and method for treating inflammation-related conditions and diseases
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
WO2016130845A1 (en) 2015-02-11 2016-08-18 Loma Linda University A method for utilizing engineered dendritic cells to induce gut-homing regulatory t cells and treat gut inflammation
UA129792C2 (uk) 2016-03-28 2025-08-06 Ейрджен Фарма Лтд. Способи лікування вітаміном d
WO2017214190A1 (en) * 2016-06-06 2017-12-14 Loma Linda University Engineered dendritic cells that express 1a-hydroxylase and uses thereof for treating immune-mediated diseases
CN107365805B (zh) * 2017-05-12 2021-08-03 太原市威尔潞威科技发展有限公司 骨化二醇发酵的补料培养基、发酵的补料方法及其发酵方法
CN114075556B (zh) * 2021-11-18 2023-08-04 江南大学 可羟基化维生素d3 c-1和c-25的p450酶及其基因、表达载体、重组菌与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554106A (en) 1984-11-01 1985-11-19 Wisconsin Alumni Research Foundation Method for preparing 1α-hydroxyvitamin D compounds
JP3024154B2 (ja) * 1990-02-06 2000-03-21 住友化学工業株式会社 チトクロムＰ４５０ｃ▲下２▼▲下５▼遺伝子
EP0477961B1 (en) 1990-09-26 1996-09-11 Sumitomo Chemical Company, Limited Mitochondrial P450
US5786191A (en) * 1992-04-09 1998-07-28 Goldstein; Joyce A. Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450 2C subfamily
US5981176A (en) * 1992-06-17 1999-11-09 City Of Hope Method of detecting and discriminating between nucleic acid sequences
US5593833A (en) * 1992-07-31 1997-01-14 Garvan Institute Of Medical Research Assessment of allelic variation in vitamin D receptor correlated to bone density or turnover
EP1024193A4 (en) 1997-07-22 2004-12-15 Chugai Pharmaceutical Co Ltd METHOD FOR SCREENING GENES USING CELL CORE RECEPTORS.
US6096876A (en) 1997-08-06 2000-08-01 Shriners Hospitals For Children 1-α-hydroxylase materials and methods
CN1301298A (zh) 1998-03-25 2001-06-27 卡坦诺根公司 用于预防和治疗癌症的方法

Also Published As

Publication number Publication date
US20020031798A1 (en) 2002-03-14
CA2237138A1 (en) 1999-01-10
EP1074627A3 (en) 2001-04-04
US6274359B1 (en) 2001-08-14
EP0890643A2 (en) 1999-01-13
EP0890643A3 (en) 1999-04-28
EP1074627A2 (en) 2001-02-07

Similar Documents

Publication Publication Date Title
JPH1175863A (ja) ２５−ヒドロキシビタミンＤ３−１α−水酸化酵素および該酵素をコードするＤＮＡ
JP4112374B2 (ja) 血管新生マーカーとなるポリペプチドおよびそのｄｎａ
EP0915156A1 (en) IgA NEPHROPATHY-ASSOCIATED GENE
JP4880116B2 (ja) 劇症ｃ型肝炎ウイルス株の遺伝子
WO2000018805A1 (fr) Nouveaux anticorps, medicaments les contenant et methodes de criblage de composes par utilisation desdits anticorps
EP1012262A1 (en) Human frezzled-like protein
WO1999031239A1 (fr) PROTEINE Nap1 HUMAINE
US20080044425A1 (en) Polypeptides having phospholipase a2 activity
EP1180525B1 (en) Transcriptional activation inhibitory protein
US20040005578A1 (en) Myocardial cell proliferation-associated genes
US6790944B1 (en) DNA encoding IGA nephropathy indicating protein
EP1205549A1 (en) Gene expressed specifically in human fetal heart muscle
WO2001066716A1 (fr) Polypeptide ayant une activite de phosphodiesterase
WO2000042180A1 (fr) Nouvelle proteine
JPWO2002064769A1 (ja) 新規疾患マーカー
JP2000189168A (ja) 新規転写伸長抑制因子
WO2000063392A1 (en) Novel tyrosine phosphatase
WO2000040609A1 (fr) Nouvelle proteine
JP2001352986A (ja) 新規ポリペプチド
JP2000041681A (ja) 新規蛋白質
JP2002272478A (ja) 新規ポリペプチド
JPWO2000040609A1 (ja) 新規蛋白質
JP2003259884A (ja) 新規ポリペプチド
JPH11236398A (ja) 新規ポリペプチド
JP2002369684A (ja) ヒトウリジンジホスフェートガラクトース−４−エピメラーゼ

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040602

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040602

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20061205

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070202

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070306